RFA's as of February 2020

AnnouncementIssuingReleaseOpening DateExpirationActivityTitle
RFA-DA-20-022NIDA11/7/20192/11/20203/12/2020R01Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01 Clinical Trial Optional)
RFA-AA-20-006NIAAA11/12/20192/24/20203/25/2020R01Impact of Alcohol on the Onset and Progression of Alzheimers Disease and Its Related Dementias (R01 - Clinical Trial Optional)
RFA-AA-20-007NIAAA1/16/20202/26/20203/27/2020U01Medications Development for the Treatment of Alcohol Use Disorder (AUD) or Alcohol-Related Organ Damage (AROD), or the Combination of AUD and AROD (U01 Clinical Trial Optional)
RFA-DA-19-003NIDA2/15/20186/17/20187/18/2020R61/R33Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)
RFA-DA-18-019NIDA12/6/20177/14/20188/15/2020DP1NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)
RFA-DA-18-022NIDA3/14/20187/22/20188/22/2020R01Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01, Clinical Trial Optional)
RFA-DA-18-020NIDA12/6/20176/25/20189/8/2020UG3/UH3NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional)
RFA-DA-19-019NIDA12/10/201812/10/20189/9/2021R43/R44HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)
RFA-DA-19-020NIDA12/10/201812/10/20189/9/2021R41/R42HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional)